Taking advantage of ApoESA/SA mice, a new model combining both hypercholesterolemia and hypertension that rapidly develops atherosclerosis (manuscript under submission), we examined the impact of RIPK1 inhibition on advanced atherosclerosis. Here, RIPK1 is linked to familial hypercholesterolemia.